Press Releases

07.25.2018
Ophthotech Corporation to Report Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 1, 2018
06.07.2018
Ophthotech Enters into Gene Therapy Agreements with the University of Florida and the University of Pennsylvania
05.09.2018
Ophthotech Reports First Quarter 2018 Financial and Operating Results
05.01.2018
Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura® in Combination with Anti-VEGF Therapy in Wet Age-Related Macular Degeneration
05.01.2018
Ophthotech Corporation to Report First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
03.06.2018
Ophthotech to Present at the Cowen and Company 38th Annual Health Care Conference
02.27.2018
Ophthotech Reports Fourth Quarter and Full Year 2017 Financial and Operating Results
02.27.2018
Ophthotech Targets Gene Therapy to Expand its Orphan and Age-Related Retinal Disease Strategy
02.21.2018
Ophthotech Corporation to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Tuesday, February 27, 2018
01.16.2018
Ophthotech Announces First Patient Enrolled in the Phase 2b Clinical Trial of Zimura®, Complement C5 Inhibitor, for the Treatment of Autosomal Recessive Stargardt Disease (STGD1)